首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >New azole antifungal agents with novel modes of action: synthesis and biological studies of new tridentate ligands based on pyrazole and triazole.
【24h】

New azole antifungal agents with novel modes of action: synthesis and biological studies of new tridentate ligands based on pyrazole and triazole.

机译:具有新型作用方式的新型唑类抗真菌剂:基于吡唑和三唑的新型三齿配体的合成和生物学研究。

获取原文
获取原文并翻译 | 示例
           

摘要

The synthesis and extensive biological study of two new tridentates ligands based on pyrazole and triazole are described. The antifungal activity against the budding yeast cells of the newly synthesized compounds was determined. These compounds were toxic to yeast cells. Cell cycle analysis suggested that treatment with these compounds impairs cell division in G1 of the cell cycle. Using yeast-based functional genomics technologies, we found that these compounds tolerance requires DNA repair pathway and SKI complex function. We have also found that the PKC1 heterozygous deletion strain was the most sensitive to these compounds using HaploInsufficiency Profiling, suggesting that the Pkc1 protein may be the target for these compounds. These results strongly suggest that these compounds induce DNA damage and thus exert a different mechanism of action compared to other azole derivatives. These two compounds might therefore represent promising lead compounds for further development of antifungal drugs for human therapy.
机译:描述了基于吡唑和三唑的两个新的三齿配体的合成和广泛的生物学研究。确定了新合成化合物对发芽酵母细胞的抗真菌活性。这些化合物对酵母细胞有毒。细胞周期分析表明,用这些化合物进行治疗会损害细胞周期G1中的细胞分裂。使用基于酵母的功能基因组学技术,我们发现这些化合物的耐受性需要DNA修复途径和SKI复杂功能。我们还发现,使用HaploInsufficiency Profiling,PKC1杂合缺失菌株对这些化合物最敏感,这表明Pkc1蛋白可能是这些化合物的靶标。这些结果强烈表明,这些化合物诱导DNA损伤,因此与其他唑衍生物相比,发挥不同的作用机理。因此,这两种化合物可能代表了有前途的先导化合物,可进一步开发用于人类治疗的抗真菌药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号